Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer

Thyroid

Volumn 18, Issue 9, 2008, Pages 943-952

  Jonklaas, Jacqueline ^a,d   Nsouli Maktabi, Hala ^b   Soldin, Steven J ^a,c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN;

ADULT; CANCER DIAGNOSIS; CANCER RISK; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; LIOTHYRONINE BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY; THYROID CANCER; THYROID TUMOR; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TRIIODOTHYRONINE;

EID: 51849112468     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0061     Document Type: Conference Paper

References (36)

1. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
2. Balme H 1954 Metastatic carcinoma of the thyroid successfully treated with thyroxine. Lancet 1:812-813.
3. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB 1988 Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063-1075.
4. Staunton MD 1994 Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival. Eur J Surg Oncol 20:613-621.
5. Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG 1980 Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nuc Med 21:733-737.
6. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A 1990 Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344-347.
7. Rossi RL, Cady B, Silverman ML, Wool MS, ReMine SG, Hodge MB, Salzman FA 1988 Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy. Arch Surg 123:569-574.
8. Sanders LE, Cady B 1998 Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 133:419-425.
9. Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C 1996 Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81:4318-4323.
10. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain KB, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T, Maxon HR 3rd 1998 Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8:737-744.
11. McGriff NJ, Csako G, Gourgiotis L, Lori CG, Pucino F, Sarlis NJ 2002 Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34:554-564.
12. Biondi B, Filetti S, Schlumberger M 2005 Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Prac 1:32-40.
13. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16:1229-1242.
14. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon HR 3rd 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021.
15. Hovens GC, Stokkel MP, Kievit J, Corssmit EP, Pereira AM, Romijn JA, Smit JW 2007 Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab 92:2610-2615.
16. Hoelting T, Tezelman S, Siperstein AE, Duh QY, Clark OH 1995 Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro. Thyroid 5:35-40.
17. Derwahl M, Broecker M, Kraiem Z 1999 Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 84:829-834.
18. Carayon P, Thomas-Morvan C, Castanas E, Tubiana M 1980 Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 51:915-920.
19. Abe Y, Ichikawa Y, Muraki T, Ito K, Homma M 1981 Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. J Clin Endocrinol Metab 52:23-28.
20. Ichikawa Y, Saito E, Abe Y, Homma M, Muraki T 1976 Presence of TSH receptor in thyroid neoplasms. J Clin Endocrinol Metab 42:395-398.
21. Clark OH, Gerend PL 1985 Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms. Surgery 97:539-546.
22. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301.
23. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814.
24. Jonklaas J, Davidson B, Bhagat S, Soldin SJ 2008 Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299:769-777.
25. Soukhova N, Soldin OP, Soldin SJ 2004 Isotope dilution tandem mass spectrometric method for T4/T3. Clin Chim Acta 343:185-190.
26. Zhang J, Lazar MA 2000 The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466.
27. de Souza Meyer EL, Dora JM, Wagner MS, Maia AL 2005 Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma. Clin Endocrinol 62:672-678.
28. Ross DS 2006 Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab 91:4253-4255.
29. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
30. Surks MI, Hollowell JG 2007 Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575-4582.
31. Hamilton TE, Davis S, Onstad L, Kopecky KJ 2008 Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 93:1224-1230.
32. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR 1995 Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76:2312-2318.
33. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP 1999 Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070-1076; discussion 1076-1077.
34. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA 2005 Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 71:874-878.
35. Kurukahvecioglu O, Taneri F, Yuksel O, Aydin A, Tezel E, Onuk E 2007 Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther 24:510-516.
36. Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, Evers BM 2007 Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 204:764-773; discussion 773-775.